London, UK – A team of researchers has developed a groundbreaking cancer treatment using artificial intelligence, offering new hope for patients worldwide. The treatment, which personalizes therapy based on genetic profiling, has shown a 90% success rate in early trials.
Lead scientist Dr. Rachel Thompson stated, “AI allows us to detect cancer at an earlier stage and customize treatments more effectively than ever before.” The new therapy significantly reduces side effects compared to traditional chemotherapy.
The medical community has hailed this as a major step in the fight against cancer. The treatment is expected to receive regulatory approval by next year, bringing new optimism to millions affected by the disease.